Homozygous <i><scp>FCGR3A</scp>‐158<scp>V</scp></i> alleles predispose to late onset neutropenia after <scp>CHOP‐R</scp> for diffuse large <scp>B</scp>‐cell lymphoma

Abstract

Polymorphic analysis may be a predictive tool to identify those at high risk of LON. Prospective studies are required to establish definitively if LON or FCGR3A-158V/V genotype influences outcome.